Cognition president and CEO, Lisa Ricciardi, attended the Sachs Neuroscience Innovation Forum (NIF), which took place during the week of the JP Morgan Healthcare Conference 2025. Ms. Ricciardi participated on a panel titled: Innovation in AD/PD & Other Cognitive Disorders, which was co-chaired by Jenny Laird of Eli Lilly and Company and Sumant Kulkarni of Canaccord Genuity. Other panelists included Alexander Gebauer of Galimedix Therapeutics, Gaia Skibinski from The Michael J. Fox Foundation and Sander van Deventer of VectorY Tx.
In addition, Ms. Ricciardi presented a corporate update at Sachs NIF, an archive of which can be viewed by clicking here.